Claret Bioscience Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Claret Bioscience is a biotechnology startup focused on advancing sequencing and DNA assay design within molecular diagnostics, with an emphasis on applications such as liquid biopsies, FFPE samples, and ancient DNA. The company situates its work in the realm of next-generation sequencing and fragmentomics, aiming to develop methods for preparing sequencing data and analyzing DNA in ways that support cancer detection and related diagnostic contexts. Based in Santa Cruz, California, the firm operates as a small, early-stage team pursuing ground-level development of its technology and collaborates with external partners to advance its workflows.

Its target market includes researchers and diagnostic developers seeking innovative sample preparation and analysis approaches for DNA methylation and fragmentation, with ongoing recruitment of scientists and opportunities for beta testing its single-stranded library preparation approach. In recent developments, Claret Bioscience announced a collaboration with New England Biolabs to copromote a sequencing workflow for methylation and fragmentation analysis, reflecting its positioning within the broader biotechnology and molecular diagnostics landscape.

Sign up for free to view info

Company overview Employee directory